HBM Holdings Ltd

HKSE:02142 (China)   Ordinary Shares
HK$ 1.45 (+0.7%) Dec 24
6.65
P/B:
1.11
Market Cap:
HK$ 1.04B ($ 136.41M)
Enterprise V:
HK$ 129.69M ($ 19.47M)
Volume:
6.07M
Avg Vol (2M):
1.87M
Trade In:
Volume:
6.07M
Avg Vol (2M):
1.87M

Business Description

Description
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 2.77
Equity-to-Asset 0.56
Debt-to-Equity 0.54
Debt-to-EBITDA 2.32
Interest Coverage 5.98
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.29
Distress
Grey
Safe
Beneish M-Score -0.3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 88.09
9-Day RSI 79.8
14-Day RSI 72.66
6-1 Month Momentum % -6.15
12-1 Month Momentum % -22.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.45
Quick Ratio 3.44
Cash Ratio 3.12
Days Inventory 92.45
Days Sales Outstanding 102.79
Days Payable 1415.84

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.3
Shareholder Yield % 15.38

Financials (Next Earnings Date:2025-03-16 Est.)

HKSE:02142's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

HBM Holdings Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 563.927
EPS (TTM) (HK$) 0.218
Beta 2.28
Volatility % 51.73
14-Day RSI 72.66
14-Day ATR (HK$) 0.06129
20-Day SMA (HK$) 1.23
12-1 Month Momentum % -22.29
52-Week Range (HK$) 1.01 - 1.95
Shares Outstanding (Mil) 730.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HBM Holdings Ltd Filings

Filing Date Document Date Form
No Filing Data

HBM Holdings Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

HBM Holdings Ltd Frequently Asked Questions

What is HBM Holdings Ltd(HKSE:02142)'s stock price today?
The current price of HKSE:02142 is HK$1.45. The 52 week high of HKSE:02142 is HK$1.95 and 52 week low is HK$1.01.
When is next earnings date of HBM Holdings Ltd(HKSE:02142)?
The next earnings date of HBM Holdings Ltd(HKSE:02142) is 2025-03-16 Est..
Does HBM Holdings Ltd(HKSE:02142) pay dividends? If so, how much?
HBM Holdings Ltd(HKSE:02142) does not pay dividend.

Press Release

Subject Date
No Press Release